[The intensive therapy of posthypoxic encephalopathy]

Area of Science:

• Neurology
• Hyperbaric Medicine
• Biochemistry

Context:

• Posthypoxic encephalopathy presents a significant clinical challenge, often resulting from diverse causes like asphyxia, carbon monoxide, narcotics, or traumatic brain injury.
• Evaluating the efficacy of complex therapeutic interventions is crucial for improving patient outcomes in this population.
• Understanding the biochemical and homeostatic changes associated with posthypoxic encephalopathy is key to developing targeted treatments.

Purpose:

• To assess the clinical efficacy and biochemical impact of a multimodal therapeutic regimen for posthypoxic encephalopathy.
• To investigate the effects of hyperbaric oxygenation, heparin, glucocorticoids, and proteolysis inhibitors on homeostasis and biochemical markers.
• To determine the treatment's influence on lipid peroxidation, blood and cerebrospinal fluid parameters, and overall patient recovery.

Summary:

• A cohort of 49 patients with posthypoxic encephalopathy received a complex therapy including hyperbaric oxygenation, heparin, glucocorticoids, and proteolysis inhibitors.
• Treatment led to significant clinical improvement in 88.6% of cases, with normalization of blood coagulation parameters and fibrinogen levels.
• Biochemical analysis revealed normalized superoxide dismutase activity but increased malonic dialdehyde, with persistent metabolic acidosis in cerebrospinal fluid despite overall positive outcomes.

Impact:

• The multimodal treatment demonstrates significant clinical benefits for patients suffering from posthypoxic encephalopathy.
• The findings provide insights into the complex biochemical responses to therapeutic interventions in hypoxic brain injury.
• Further research may explore strategies to address persistent metabolic acidosis in cerebrospinal fluid to enhance recovery from hypoxic brain injury.